Editing Adrenoleukodystrophy (section)

===Male adrenoleukodystrophy phenotypes===
{| class="wikitable"
|+ Male adrenoleukodystrophy phenotypes<ref name=scriver />
|-
! width=15% |Phenotype
! width=50% |Description
! width=15% |Onset
! width=20% |Approximate relative frequency
|-
| Childhood cerebral
| Progressive neurodegenerative decline, leading to a vegetative state without treatment
| 3–10 years
| 31–35%
|-
| Adolescent
| Similar to childhood cerebral, with a slower progression
| 11–21 years
| 4–7%
|-
| Adrenomyeloneuropathy (AMN)
| Progressive [[neuropathy]], [[paraparesis]]; approximately 40% progress to cerebral involvement
| 21–37 years
| 40–46%
|-
| Adult cerebral
| [[Dementia]], behavioral disturbances, similar progression to childhood cerebral form, but without preceding AMN phenotype
| Adulthood
| 2–5%
|-
| Olivo-ponto-cerebellar
| Cerebral and [[brain stem]] involvement
| Adolescence to adulthood
| 1–2%
|-
| "[[Addison disease]] only"
| Adrenal insufficiency
| Before 7.5 years
| Up to 50% in childhood, varies with age
|-
| Asymptomatic
| No clinical presentation, further studies can reveal subclinical adrenal insufficiency or mild AMN phenotype
| Most common phenotype in boys under four years of age
| Proportion of asymptomatic patients decreases with age
|}